Regulatory Affairs professional, critical thinker, problem solver and collaborator
This seems like an informative workshop in clinical pharmacology (May 8-9). I am very interested in Session 2 on considerations for specific patient subpopulations and Session 3 applications for rare disease drug development. Check it out at: https://lnkd.in/gx6vafqw #FDA #ClinicalPharmacology
Greetings to all... I completed my course in Introduction to Clinical Pharmacology and Therapeutics with Dr. Juan J.L Lertora This course helps me to understand how the body and diseases react to drug treatments, which is why they are often involved in clinical trials. The core goal of Clinical Pharmacology and Therapeutics is to improve patient care through the safe and effective use of medicines.
New webinar available on-demand: Clinical Pharmacology & Model-Informed Drug Development (MIDD) Insights for Targeted Radiation Therapies (TRT). Hear from our team of experts to learn how MIDD can address the unique considerations and challenges in TRT development! Watch on-demand: https://ow.ly/zKZl50STpPz #ClinicalPharmacology #Pharmacometrics #QuantitativeSystemsPharmacology #Radiopharmaceuticals #TargetedRadiationTherapies #DrugDevelopment
Read the post: https://bit.ly/4fYAG8j Clinical #pharmacology studies gather crucial information to mitigate risks for #patients, and this #data informs the product label/SmPC. Elsa Lilienberg delves into the fundamentals and how to conduct #clinical pharmacology studies effectively to optimize #drug development outcomes.
Read the post: https://hubs.ly/Q02QX61W0 Clinical #pharmacology studies gather crucial information to mitigate risks for #patients, and this #data informs the product label/SmPC. Elsa Lilienberg delves into the fundamentals and how to conduct #clinical pharmacology studies effectively to optimize #drug development outcomes.
We are excited to share our latest research publication titled "Pharmacogenetic Variations in Arab Populations: Clinical Implications for Personalized Drug Therapy," now featured in a Q1 journal (Current Reviews in Clinical and Experimental Pharmacology) by Bentham Publishers, achieving an impressive percentile of 83%! This study, published by Al-Eitan Lab, sheds light on the unique pharmacogenetic variations within Arab populations and explores their significant implications for personalized medicine and drug therapy. We believe this work will contribute to a deeper understanding of how genetic factors influence drug response, ultimately advancing precision healthcare for diverse populations. Read the full article here [https://lnkd.in/e7--k6g8] and join us in driving forward the future of personalized drug therapy! #Pharmacogenetics #PersonalizedMedicine #HealthcareInnovation #ArabPopulations #Research #DrugTherapy #ClinicalImplications #BenthamPublishers #PrecisionMedicine #Q1Journal #HealthEquity
Here you go! Make sure you tune in and don't miss out! This webinar will discuss the final guidance for the industry on Clinical Pharmacology Considerations for Human Radiolabeled Mass Balance Studies which was published in July 2024. https://lnkd.in/ebEkMNHy
Two weeks today Altasciences will be hosting the symposium 'Current Trends for Efficient Drug Development' on Campus. Speakers include Robert Wilson, Drug Development and Clinical Pharmacology Director, at Healx who will share details of incorporating AI in drug discovery. Other topics will include regulatory pathways to conduct first-In-human trials in Canada and the journey of an obesity compound that has been 20 years in the making. Registration is essential - https://ow.ly/P69f50RFGlt
Quantitative Systems Pharmacology (QSP) supports rare disease development Pompe disease is a rare and complex condition with severe infantile-onset (IOPD) and late-onset (LOPD) forms. To better understand treatment efficacy for IOPD patients, Sanofi’s team developed a quantitative systems pharmacology (QSP) "digital twin" model, leveraging Certara’s Virtual Twin technology. This innovative approach created virtual patient profiles to compare the effects of avalglucosidase alfa vs. the current standard of care. The findings highlight enhanced tissue glycogen clearance with avalglucosidase alfa, providing new insights into its mechanism of action and showcasing the power of digital twin technology in rare disease drug development. Check out this recent publication by Sanofi, supported by Certara’s QSP Center of Excellence: https://ow.ly/7UMi50UtB2X #RareDisease #PompeDisease #VirtualTwinTechnology #QuantitativeSystemsPharmacology #DrugDevelopment #PrecisionMedicine
I'm thrilled to announce my participation alongside an outstanding group of researchers in publishing our study: "Pharmacogenetic Variations in Arab Populations: Clinical Implications for Personalized Drug Therapy." This work highlights the importance of tailoring drug therapies based on genetic variations specific to Arab populations, paving the way for more effective and safer treatments. #Pharmacogenetics #PersonalizedMedicine #ArabHealth #ClinicalResearch #Genetics
We are excited to share our latest research publication titled "Pharmacogenetic Variations in Arab Populations: Clinical Implications for Personalized Drug Therapy," now featured in a Q1 journal (Current Reviews in Clinical and Experimental Pharmacology) by Bentham Publishers, achieving an impressive percentile of 83%! This study, published by Al-Eitan Lab, sheds light on the unique pharmacogenetic variations within Arab populations and explores their significant implications for personalized medicine and drug therapy. We believe this work will contribute to a deeper understanding of how genetic factors influence drug response, ultimately advancing precision healthcare for diverse populations. Read the full article here [https://lnkd.in/e7--k6g8] and join us in driving forward the future of personalized drug therapy! #Pharmacogenetics #PersonalizedMedicine #HealthcareInnovation #ArabPopulations #Research #DrugTherapy #ClinicalImplications #BenthamPublishers #PrecisionMedicine #Q1Journal #HealthEquity
TL;DR: 1st levothyroxine MIPD for use in primary care suggests higher accuracy than conventional age or weight-based methods (using retrospective data + clinical simluation trials) American Society for Clinical Pharmacology & Therapeutics: ➡ https://bit.ly/3Vurpgu | #ModelInformedPrecisionDosing #MIPD #PresicionMedicine #PrecisionDosing #Levothyroxine